What are the indications of treatment in acute hepatitis C?;Quelles sont les indications du traitement dans l'hepatite aigue C?

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 1 BIS, 1997, Pages

  Poynard, Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

acute hepatitis C; interferon; meta analysis; randomized trial; treatment

Indexed keywords

ALPHA2B INTERFERON; BETA INTERFERON; INTERFERON;

ACUTE HEPATITIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030886880     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Germanaud J, Causse X, Dhumeaux D. Transmission de l'hépatite C lors des piqûres accidentelles. Evaluation du risque. Presse Med 1994;23:1078-82.
2. Maillard M, Poynard T, Dubreuil P, Agostini H, Hautecœur B, Pillot J, et al. Prévalence des anticorps sériques anti-virus de l'hépatite C et des facteurs de risque de contamination chez le personnel d'un hôpital de la région parisienne. Une enquête prospective. Gastroenterol Clin Biol 1996;20:1053-7.
3. Poynard T, Leroy V, Cohard M, Thévenot T, Mathurin M, Opolon P, et al. Metaanalysis of Interferon randomized trials in the treatment of viral hepatitis C. Effects of dose and duration. Hepalology 1996;24:778-89.
4. Alberti A, Chemello L, Belussi F, Pontisso P, Tisminetzky S, Gerotto M, et al. Outcome of acute hepatitis C and role of alpha interferon therapy. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994:604-6.
5. Lampertico P, Rumi M, Romeo R, Craxi A, Soffredini R, Biassoni D, et al. A multicenter randomized controlled trial of recombinant interferon alpha-2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994;19:19-22.
6. Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Cooperative Study Group. Effect of Interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Gastroenterology 1994;107:805-11.
7. Viladomiu L, Genesea J, Esteban JI, Allende H, Gonzalez A, Lopez-Talavera JC, et al. Interferon-alpha in acute post-transfusion hepatitis C: a randomized, controlled trial. Hepatology 1992;15:767-9.
8. Hwang SJ. Lee SD, Chan CY, Lu RH, Lo KJ. A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 1994;21:861-6.
9. Tassopoulos NC, Koutelou MG, Papatheodoridis G. Recombinant human interferon alpha-2b treatment for acute non-A, non-B hepatitis. Gut 1993;34 (suppl.):S130-2.
10. Esteban R. Is there a role for interferon in acute viral hepatitis ? Gut 1993;34 (suppl.):S77-80.
11. Colombo M, Lampertico P, Rumi M. Multicentre randomised controlled trial of recombinant interferon alpha-2b in patients with acute non-A, non-B/type C after transfusion. Gut 1993;34 (suppl.):S141.
12. Camma C. Almasio P, Craxi A. Interferon as a treatment for acute hepatitis C. A metaanalysis. Dig Dis Sci 1996;41:1248-55.
13. Krawezynski K, Alter MJ, Tankersley DL, Beach M, Robertson BH, Lambert S, et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996;173:822-8.